Evidence map›Paper›PMID 36159644›Full record

ArticleFrontiers in cellular and infection microbiology2022

Antibiotic resistance of

Zongdan Jiang, Xuetian Qian, Zhi Wang, Yunfan Dong, Yuqin Pan, Zhenyu Zhang, Shukui Wang

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06299605 (Triple Versus Quadruple Therapy with Amoxicillin and Tetracycline for the Eradication of Helicobacter Pylori), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06299605 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Triple Versus Quadruple Therapy with Amoxicillin and Tetracycline for the Eradication of Helicobacter Pylori: a Multicenter Randomized Controlled Trial

TypeinterventionalSponsorShandong UniversityRan2024 to 2025Enrolled375ConditionsHelicobacter Pylori InfectionArmsVonoprazan-Amoxicillin-Tetracycline-Bismuth quadruple regimen for 14 days, Vonoprazan-Amoxicillin-Tetracycline triple regimen for 14 days, Vonoprazan-Amoxicillin-Tetracycline triple regimen for 7 days
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Antibiotic resistance and associated gene mutations ofFrontiers in cellular and infection microbiology · 2026
    Article
  2. Phenotypic and genotypic analysis ofFrontiers in cellular and infection microbiology · 2026
    Article
  3. Article
  4. Antibiotic resistance ofWorld journal of gastroenterology · 2025
    Article
  5. Article
  6. Clinical evaluation of a novelFrontiers in cellular and infection microbiology · 2025
    Observational
  7. Success of susceptibility-guided eradication ofWorld journal of gastroenterology · 2024
    Article
  8. Antibiotic resistance ofFrontiers in cellular and infection microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zongdan JiangDepartment of Gastroenterology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Xuetian QianDepartment of Gastroenterology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Zhi WangDepartment of Gastroenterology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Yunfan DongDepartment of Gastroenterology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Yuqin PanGeneral Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Zhenyu ZhangDepartment of Gastroenterology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Shukui WangGeneral Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing antibiotic resistance of

Indexed as

Helicobacter InfectionsHelicobacter pyloriAmoxicillinAnti-Bacterial AgentsChinaClarithromycinDrug Resistance, BacterialDrug Resistance, MicrobialFurazolidoneHumansLevofloxacinMetronidazoleMicrobial Sensitivity TestsTetracyclineUreaUreaseAmoxicillinAnti-Bacterial AgentsClarithromycinFurazolidoneLevofloxacinMetronidazoleTetracyclineUreaUreaseantibiotic resistanceARMS-PCRclarithromycinHelicobacter pyloriNanjing

Identifiers

PMID36159644
PMCPMC9493266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.